期刊文献+

基于单核苷酸多态性分型的系列特异嵌合体定量方法的建立 被引量:1

Quantitative analysis of lineage-specific chimerism using real-time PCR and single nucleotide polymorphisms
原文传递
导出
摘要 目的建立基于单核苷酸多态性(SNP)分型的系列特异嵌合体定量方法。方法用免疫磁珠分选技术分离CD3+T淋巴细胞和CD?s粒细胞,利用TaqMan探针建立实时荧光定量聚合酶链反应(PCR)法,对模拟血细胞嵌合体进行检测,并作出标准曲线,以评价该法的灵敏性和特异性。结果免疫磁珠分选技术分选血细胞纯度可达94%~97%。所选的SNP位点在供受者间至少有两个可区分彼此的信息位点。扩增产物中供受者嵌合百分比的对数同实时荧光定量PCR检测的Ct值显著直线相关,线性相关系数r〉0.98,灵敏度不低于0.1%,特异性亦较好。采用实时荧光定量SNP—PCR定量分析同期4例临床病例,根据模拟嵌合体标准曲线对其中1例计算,得到的嵌合率为87.50%。结论基于SNP分型的TaqMan探针实时荧光定量PCR法灵敏度高,特异性好,可用于造血干细胞移植术后血细胞嵌合体的检测。 Objective To develop a real-time quantitative PCR method with TaqMan probe to analysis the lineage-specific chimerism based on single nucleotide polymorphisms (SNP). Methods CD3 positive and CD15 positive cells were separated by magnetic cell sorting system from cord blood, and a quantitative method were established using real-time quantitative PCR and SNP. Detect the artificial chimerism and mark the standard curves. The reaction system was optimized, and the sensitivity and specificity were evaluated. Results Separation purity of blood cells by magnetic cell sorting system was up to 94 %-97 %. Discrimination between donor and recipient was possible. Dilution experiments of the mock chimerism sample revealed that Ct values correlated linearly with the logarithm of recipient/donor DNA fraction (r 〉 0.98), and the limit of detection for a minor DNA percentage was under 0.1%, and the specificity was also good.Quantitative analysis of 4 clinical cases in same period were made by real-time fluorescence quantitative SNP-PCR, the fitted rate was 87.50 % based on the chimera standard curve calculated for 1 case. Conclusion The method shows high sensitivity and specificity, and will be used to quantify the lineage- specific chimerism after allogeneic hematopoietic stem cell transplantation.
出处 《白血病.淋巴瘤》 CAS 2012年第9期531-533,共3页 Journal of Leukemia & Lymphoma
基金 山西医科大学科技创新项目(01200809)
关键词 多态性 单核苷酸 嵌合体 TAQMAN探针 造血干细胞移植 Polymorphisms, single nucleotide Chimerism TaqMan probe Stem cell transplantation
  • 相关文献

参考文献8

  • 1Bertheas MF, Lafage M, Levy P, et al. Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia. Blood, 1991, 78: 3103-3106.
  • 2Childs R, Clave E, Contentin N, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: fuU donor T-cell chimerism precedes alloimmune responses. Blood, 1999, 94: 3234-3241.
  • 3Hochberg EP, Miklos DB, Neuberg D, et al. A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. Blood, 2003, 101:363-369.
  • 4Eshel R, Vainas 0, Shpringer M, et al. Highly sensitive patient- specific real-time PCR SNP assay for chimerism monitoring after allngeneic stem cell transplantation. Lab Hematol, 2006, 12: 39-46.
  • 5Oliver DH, Thompson RE, Griffin CA, et al. Use of single nueleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis. J Mol Diagn, 2000, 2: 202-208.
  • 6Mart nez-L O pez J, Crooke A, Grande S, et al. Real-time PCR quantification of haematopoietic chimerism after transplantation: a comparison between TaqMan and hybridizalion probes technologies. Int J Lab Hematol, 2010, 32(1 Pt 1): e17-25.
  • 7Koldehoff M, Steckel NK, Hlinka M, et al.Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences. Am J Hematol, 2006, 81: 735-746.
  • 8Zeiser R, Spyridonidisl A, Wa.sch R, et at. Evaluation of immunomodulatory treatment based on conventional and lineage- specific chimerism analysis in patients with myeloid malignancies after myeloablativc allogeneie hematopoietic cell transplantation. Leukemia, 2005, 19: 814-821.

同被引文献13

  • 1刁建峰,宋利,闻庆,任云,侯建霞.紫杉醇联合顺铂治疗晚期非小细胞肺癌的临床观察[J].肿瘤研究与临床,2005,17(S1):28-29. 被引量:2
  • 2魏嘉,刘宝瑞,王亚平,钱晓萍.DNA修复基因单核苷酸多态性与铂类药物抵抗研究进展[J].中华肿瘤杂志,2006,28(3):161-163. 被引量:31
  • 3王翌庆,匡唐洪,刘云霞,姚勇伟,蒋沈君,杨洁文.国产吉西他滨加顺铂治疗晚期非小细胞肺癌的临床研究[J].肿瘤研究与临床,2006,18(6):405-406. 被引量:6
  • 4陈芹,周彩存,张颉.ERCC1、RRM1和BRCA1在非小细胞肺癌中的表达及预后意义[J].肿瘤,2007,27(9):719-722. 被引量:57
  • 5Rosell R,Lord RV,Taron M,et al.DNA repair and cisplatin resistance in non-small-cell lung cancer.Lung Cancer,2002,38:217-227.
  • 6Viguier J,Boige V,Miquel C,et al.ERCC 1 colon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.Clin Cancer Res,2005,11:6212-6217.
  • 7Park DJ,Zhang W,Stoehlmaeher,et al.ERCC 1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.Clin Adv Hematol Oncol,2003,1:162-166.
  • 8Zhou C,Ren S,Zhou S,et al.Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.Jpn J Clin Oncol,2010,40:954-960.
  • 9Ryu JS,Hong YC,Han HS,et al.Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.Lung Cancer,2004,44:311-316.
  • 10Isla D,Sarries C,Rosell R,et al.Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer.Ann Oncol,2004,15:1194-1203.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部